Cargando…
Recent Advances in Toxoplasma gondii Immunotherapeutics
Toxoplasmosis is an opportunistic infection caused by the protozoan parasite Toxoplasma gondii. T. gondii is widespread globally and causes severe diseases in individuals with impaired immune defences as well as congenitally infected infants. The high prevalence rate in some parts of the world such...
Autores principales: | Lim, Sherene Swee-Yin, Othman, Rofina Yasmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Parasitology and Tropical Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277020/ https://www.ncbi.nlm.nih.gov/pubmed/25548409 http://dx.doi.org/10.3347/kjp.2014.52.6.581 |
Ejemplares similares
-
Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts by Toxoplasma gondii
por: Lim, Sherene Swee Yin, et al.
Publicado: (2018) -
DNA repair mechanisms and Toxoplasma gondii infection
por: Smolarz, Beata, et al.
Publicado: (2013) -
Secretory traffic in the eukaryotic parasite Toxoplasma gondii
: less is more
por: Joiner, Keith A., et al.
Publicado: (2002) -
Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review
por: Hajissa, Khalid, et al.
Publicado: (2019) -
Research advances in microneme protein 3 of Toxoplasma gondii
por: Wang, Yanhua, et al.
Publicado: (2015)